Certain Shares of Everest Medicines Limited are subject to a Lock-Up Agreement Ending on 9-OCT-2021. These Shares will be under lockup for 366 days starting from 8-OCT-2020 to 9-OCT-2021.

Details:
Each Controlling Shareholder has undertaken to each of the Stock Exchange and Company that, except pursuant to the Global Offering (including the Over-allotment Option) or the Stock Borrowing Agreement, he/she/it shall not and shall procure that the relevant registered holder(s) (if any) shall not, without the prior written consent of the Stock Exchange or unless otherwise in compliance with the Listing Rules in the period commencing on the date by reference to which disclosure of his or its shareholding is made in this document and ending on the date which is six months from the Listing Date, dispose of, or enter into any agreement to dispose of or otherwise create any options, rights, interests or encumbrances in respect of, any of Shares, in the period of six months commencing from the expiry of the period referred to in paragraph (i) above, dispose of, or enter into any agreement to dispose of or otherwise create any options, rights, interests or encumbrances in respect of any of the Relevant Securities if, immediately following such disposal or upon the exercise or enforcement of such options, rights, interests or encumbrances, he/she/it would cease to be a controlling shareholder.